Children with medical complexity: an emerging population for clinical and research initiatives

Eyal Cohen1, Dennis Z Kuo, Rishi Agrawal

  • 1Division of Pediatric Medicine, Hospital for Sick Children, 555 University Ave, Toronto, Ontario, Canada M5G 1X8. eyal.cohen@sickkids.ca

Pediatrics
|February 23, 2011
PubMed

Insights

Children with medical complexity (CMC) require better healthcare models. This study defines CMC and proposes a research agenda to improve care for these medically fragile children and their families.

Area of Science:

  • Pediatric Healthcare
  • Complex Care Management
  • Health Services Research

Background:

  • Children with medical complexity (CMC) face significant health challenges and intensive care needs unmet by current healthcare systems.
  • These children often have multisystem diseases, severe functional impairments, or technology dependence, placing them at risk for adverse health and family outcomes.
  • Limited research and clinical initiatives exist to improve care for CMC.

Purpose of the Study:

  • To present a definitional framework for Children with Medical Complexity (CMC).
  • To explore existing care models for CMC.
  • To propose a research agenda for improving CMC care using a uniform definition.

Main Methods:

  • Developed a definitional framework for CMC based on service needs, chronic conditions, functional limitations, and healthcare utilization.
  • Reviewed and analyzed diverse existing care models for CMC.
  • Applied principles of the Chronic Care Model to address CMC needs.
  • Suggested a research agenda with a uniform definition for population description and outcome evaluation.

Main Results:

  • A definitional framework for CMC was established, incorporating family-identified needs, severe chronic conditions, functional limitations, and high healthcare use.
  • Existing care models for CMC were explored, highlighting diversity in approaches.
  • The Chronic Care Model principles were applied to guide improvements in CMC care.
  • A research agenda was proposed to standardize CMC population definition and evaluate outcomes.

Conclusions:

  • A clear definition of Children with Medical Complexity (CMC) is crucial for targeted research and improved care delivery.
  • Applying the Chronic Care Model offers a framework for enhancing healthcare services for CMC.
  • Further research is needed to evaluate outcomes from child, family, and system perspectives using a standardized definition.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Methods of Documentation VI: Case Management Model01:15

Methods of Documentation VI: Case Management Model

The case management model is a multidisciplinary approach that involves healthcare professionals from diverse disciplines, such as physicians, nurses, therapists, social workers, and pharmacists, working collaboratively to address the various needs of patients. Each healthcare professional brings unique expertise and perspectives, contributing to a more comprehensive understanding of the patient's condition and tailoring treatment plans accordingly.
For example, a patient with a chronic illness...
Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...